UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	April 15, 2021 4:00 P.M.

Form:	S-3
CIK: 0001341235 Company Name: Aldeyra Therapeutics, Inc. File Number: 333-254175